Evidence map›Paper›PMID 28466401›Full record

ArticleEndocrine2018

Is levothyroxine requirement the same for tablet and soft gel formulations?

Vincenzo Di Donna, Rosa Maria Paragliola, Chiara de Waure, Giampaolo Papi, Alfredo Pontecorvi, Salvatore Maria Corsello

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. L-T4 Therapy in Enteric Malabsorptive Disorders.Frontiers in endocrinology · 2021
    Review
  8. Review
  9. Levothyroxine Therapy in Thyrodectomized Patients.Frontiers in endocrinology · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vincenzo Di DonnaUnit of Endocrinology, Università Cattolica del Sacro Cuore, largo Agostino Gemelli 8, 00168, Rome, Italy.
Rosa Maria ParagliolaUnit of Endocrinology, Università Cattolica del Sacro Cuore, largo Agostino Gemelli 8, 00168, Rome, Italy.
Chiara de WaureInstitute of Public Health, Università Cattolica del Sacro Cuore, largo Agostino Gemelli 8, 00168, Rome, Italy.
Giampaolo PapiUnit of Endocrinology, Università Cattolica del Sacro Cuore, largo Agostino Gemelli 8, 00168, Rome, Italy.
Alfredo PontecorviUnit of Endocrinology, Università Cattolica del Sacro Cuore, largo Agostino Gemelli 8, 00168, Rome, Italy.
Salvatore Maria CorselloUnit of Endocrinology, Università Cattolica del Sacro Cuore, largo Agostino Gemelli 8, 00168, Rome, Italy. corsello.sm@meridiaroma.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug CompoundingAdultAgedCapsulesCross-Over StudiesFemaleHormone Replacement TherapyHumansMaleMiddle AgedTabletsThyroidectomyThyroxineTreatment OutcomeCapsulesTabletsThyroxine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.